MILFORD, Conn., Feb. 12, 2019 /PRNewswire/ -- A new study published in HIMSS' peer-reviewed Online Journal of Nursing Informatics concludes that continuous clinical surveillance possesses seven simultaneous attributes that make it distinct, in both theory and practice, from patient monitoring.
In defining the concept of clinical surveillance, while demonstrating use-models in practice, the paper's author, Mary Jahrsdoerfer, Ph.D, RN, Chief Nursing Informatics Officer of Bernoulli Health, suggests that operationalizing clinical surveillance within a hospital or health system, aligning it with clinical practice and system functionality and applying it to a safer and more proactive patient environment begins with "clarity of meaning."
Dr. Jahrsdoerfer argues that continuous clinical surveillance is driven concurrently by seven defining attributes or characteristics that proactively drive early interventions to adverse patient events: Attention, timeliness, recognition, intuition, analysis, action and collaboration.
Patient monitoring may possess one or more of these attributes, clinical surveillance requires all seven.
"The core of continuous clinical surveillance is 'real-time' attention, recognition and analysis that allows for action and collaboration. It is a paradigm shift from a retrospective clinical response, to a prospective anticipation and planning," Dr. Jahrsdoerfer said.
Continuous clinical surveillance enables the real-time acquisition, analysis and distribution of essential patient data from multiple sources for ongoing, comprehensive and prospective clinical decision-making and intervention.
In contrast, patient monitoring, which include vital sign spot-checks and notifications sent from individual physiologic devices, is often fragmented, episodic and reactive—putting patients at risk for a sentinel event or emergency intervention.
A recent KLAS report notes that "clinical surveillance tools hold the promise of giving caregivers clinically actionable insights that decrease mortality, reduce readmissions, and improve overall patient outcomes, and clinicians expect these alerts to be embedded directly within their workflow."
"The technology, clinical workflow and protocols applied to patient safety measures in health systems have evolved to the point where 'patient monitoring' and 'continuous clinical surveillance' have become wholly separate capabilities," said Janet Dillione, CEO of Bernoulli Health. "Fortunately, advances in continious clinical surveillance technology and distribution have made a more holistic and proactive patient safety environment an achievable reality."
Continuous Clinical Surveillance at HIMSS
Bernoulli Health will showcase the tangible patient safety benefits of prospective continuous clinical surveillance in general education and the Exhibit Hall demonstrations at the 2019 Annual HIMSS Conference & Exhibition, Feb. 11-15, in Orlando.
About Bernoulli
Bernoulli is the leader in real-time solutions for patient safety, with more than 1,200 installed, operational systems. Bernoulli One™ is the market's only real-time, connected healthcare platform that combines comprehensive and vendor-neutral medical device integration with powerful middleware, clinical surveillance, telemedicine/virtual ICU, advanced alarm management, predictive analytics and robust distribution capabilities into ONE solution that empowers clinicians with tools to drive better patient safety, clinical outcomes, patient experience, and provider workflow. For more information about Bernoulli One™, visit www.bernoullihealth.com. Follow us on Twitter and LinkedIn. Visit our Resource Center to download case studies, white papers and articles.
Media contacts:
Matt Schlossberg
Amendola Communications for Bernoulli
(630) 935-9136
mschlossberg@acmarketingpr.com
SOURCE Bernoulli
